Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.2127 | 8 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.18784 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.1924 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.14226 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.13637 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.23938 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.18408 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.17153 | 8 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.16061 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.18034 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.17774 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.16515 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.18337 | 8 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.18069 | 8 |